Received date: 17 May 2016
Accepted date: 28 Jul 2016
Published date: 04 Nov 2016
Copyright
Periodontitis is a polymicrobial disease inciting inflammatory destruction of the tooth-supporting tissues, i.e., periodontium. The initiation of this infectious disease is ascribed to the formation of subgingival biofilms. These biofilms cause stimulation of myriad of chronic inflammatory reactions by the affected tissue. The Gram-negative anaerobe Porphyromonas gingivalis is commonly found as part of the microbiota of subgingival biofilms, and is involved in the occurrence of the disease. P. gingivalis possesses numerous virulence factors supporting its survival, regulating its communication with other species in the biofilm, degrading host tissues. Fusobacterium nucleatum is pivotal for formation of biofilm and promotes growth and invasion properties of P. gingivalis. Bestatin is an aminopeptide inhibitor, produced by actinomycetes. It possesses antibacterial properties against P. gingivalis and F. nucleatum. The following review focuses on action of bestatin on the mentioned bacteria.
Key words: bestatin; Porphyromonas gingivalis; Fusobacterium nucleatum; periodontitis; biofilm
Hansa Jain . Antibacterial effect of bestatin during periodontitis[J]. Frontiers in Biology, 2016 , 11(5) : 387 -390 . DOI: 10.1007/s11515-016-1418-y
1 |
Araújo V M, Melo I M, Lima V (2015). Relationship between periodontitis and rheumatoid arthritis: review of the literature. Mediators Inflamm, 2015: 259074
|
2 |
Bao K, Belibasakis G N, Thurnheer T, Aduse-Opoku J, Curtis M A, Bostanci N (2014). Role of Porphyromonas gingivalisgingipains in multi-species biofilm formation. BMC Microbiol, 14:258
|
3 |
Boström E A, Kindstedt E, Sulniute R, Palmqvist P, Majster M, Holm C K, Zwicker S, Clark R, Önell S, Johansson I, Lerner U H, Lundberg P (2015). Increased eotaxin and MCP-1 levels in serum from individuals with periodontitis and in human gingival fibroblasts exposed to pro-inflammatory cytokines. PLoS ONE, 10(8): e0134608
|
4 |
Cutler C W, Kalmar J R, Genco C A (1995). Pathogenic strategies of the oral anaerobe, Porphyromonas gingivalis. Trends Microbiol, 3(2): 45–51
|
5 |
Dahlén G G (1993). Black-pigmented gram-negative anaerobes in periodontitis. FEMS Immunol Med Microbiol, 6(2-3): 181–192
|
6 |
de Diego I, Veillard F, Sztukowska M N, Guevara T, Potempa B, Pomowski A, Huntington J A, Potempa J, Gomis-Rüth F X (2014). Structure and mechanism of cysteine peptidase gingipain K (Kgp), a major virulence factor of Porphyromonas gingivalis in periodontitis. J Biol Chem, 289(46): 32291–32302
|
7 |
Gonzales J R (2015). T- and B-cell subsets in periodontitis. Periodontol 2000, 69(1): 181–200
|
8 |
Grenier D (1992). Effect of protease inhibitors on in vitro growth of Porphyromonas gingivalis. Microb Ecol Health Dis, 5(3): 133–138
|
9 |
Grenier D, Michaud J (1994). Selective growth inhibition of Porphyromonas gingivalis by bestatin. FEMS Microbiol Lett, 123(1-2): 193–199
|
10 |
Hajishengallis G (2014). Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. Trends Immunol, 35(1): 3–11
|
11 |
Hossain A, Heron D, Davenport I, Huckaba T, Graves R, Mandal T, Muniruzzaman S, Wang S, Bhattacharjee P S (2016). Protective effects of bestatin in the retina of streptozotocin-induced diabetic mice. Exp Eye Res, 149: 100–106
|
12 |
Ishizuka M, Sato J, Sugiyama Y, Takeuchi T, Umezawa H (1980). Mitogenic effect of bestatin on lymphocytes. J Antibiot (Tokyo), 33(6): 653–662
|
13 |
Jauregui C E, Wang Q, Wright C J, Takeuchi H, Uriarte S M, Lamont R J (2013). Suppression of T-cell chemokines by Porphyromonas gingivalis. Infect Immun, 81(7): 2288–2295
|
14 |
Kitano S, Irimura K, S Tasaki N, Abe A, Baba Y, Miyake N, Katunuma K, Yamamoto (2001). Suppression of gingival inflammation induced by Porphyromonas gingivalis in rats by leupeptin. Jpn J Pharmacol, 85(1): 84–91
|
15 |
Labbé S, Grenier D, Plamondon P, Uitto V J, Mayrand D (2001). Effects of dipeptide bestatin on Porphyromonas gingivalis and epithelial cells. J Periodontol, 72(6): 714–721
|
16 |
Lamont R J, Jenkinson H F (2000). Subgingival colonization by Porphyromonas gingivalis. Oral Microbiol Immunol, 15(6): 341–349
|
17 |
Li Y, Guo H, Wang X, Lu Y, Yang C, Yang P (2015). Coinfection with Fusobacterium nucleatum can enhance the attachment and invasion of Porphyromonas gingivalis or Aggregatibacter actinomycetemcomitans to human gingival epithelial cells. Arch Oral Biol, 60(9): 1387–1393
|
18 |
Liu S, Xie F, Wang H, Liu Z, Liu X, Sun L, Niu Z (2015). Ubenimex inhibits cell proliferation, migration and invasion in renal cell carcinoma: the effect is autophagy-associated. Oncol Rep, 33(3): 1372–1380
|
19 |
Lkhagvaa B, Tani K, Sato K, Toyoda Y, Suzuka C, Sone S (2008). Bestatin, an inhibitor for aminopeptidases, modulates the production of cytokines and chemokines by activated monocytes and macrophages. Cytokine, 44(3): 386–391
|
20 |
Mishima Y, Terui Y, Sugimura N, Matsumoto-Mishima Y, Rokudai A, Kuniyoshi R, Hatake K (2007). Continuous treatment of bestatin induces anti-angiogenic property in endothelial cells. Cancer Sci, 98(3): 364–372
|
21 |
Nakamura H, Suda H, Takita T, Aoyagi T, Umezawa H, Iitaka Y (1976). X-ray structure determination of (2S, 3R)-3-amino-2-hydroxy-4-phenylbutanoic acid, a new amino acid component of bestatin. J Antibiot (Tokyo), 29(1): 102–103
|
22 |
Rogers A H, Gunadi A, Gully N J, Zilm P S (1998). An aminopeptidase nutritionally important to Fusobacterium nucleatum. Microbiology, 144(Pt 7): 1807–1813
|
23 |
Rubinstein I, Potempa J, Travis J, Gao X P (2001). Mechanisms mediating Porphyromonas gingivalis gingipain RgpA-induced oral mucosa inflammation in vivo. Infect Immun, 69(2): 1199–1201
|
24 |
Signat B, Roques C, Poulet P, Duffaut D (2011). Fusobacterium nucleatum in periodontal health and disease. Curr Issues Mol Biol, 13(2): 25–36
|
25 |
Sippert E A, de Oliveira e Silva C, Ayo C M, Marques S B, Visentainer J E, Sell A M (2015). de Oliveira e Silva C, Ayo CM, Marques SB, Visentainer JE, Sell AM (2015). HLA haplotypes and genotypes frequencies in Brazilian chronic periodontitis patients. Mediators Inflamm, 2015: 481656
|
26 |
Suda H, Takita T, Aoyagi T, Umezawa H (1976). The structure of bestatin. J Antibiot (Tokyo), 29(1): 100–101
|
27 |
Umezawa H, Aoyagi T, Suda H, Hamada M, Takeuchi T (1976). Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes. J Antibiot (Tokyo), 29(1): 97–99
|
28 |
Umezawa H, Ishizuka M, Aoyagi T, Takeuchi T (1976). Enhancement of delayed-type hypersensitivity by bestatin, an inhibitor of aminopeptidase B and leucine aminopeptidase. J Antibiot (Tokyo), 29(8): 857–859
|
29 |
Wang H Y, Cheng J W, Yu H Y, Lin L, Chih Y H, Pan Y P (2015). Efficacy of a novel antimicrobial peptide against periodontal pathogens in both planktonic and polymicrobial biofilm states. Acta Biomater, 25: 150–161
|
30 |
Wang X, Niu Z, Jia Y, Cui M, Han L, Zhang Y, Liu Z, Bi D, Liu S (2016). Ubenimex inhibits cell proliferation, migration and invasion by inhibiting the expression of APN and inducing autophagic cell death in prostate cancer cells. Oncol Rep, 35(4): 2121–2130
|
31 |
Yoshioka M, Grenier D, Mayrand D (2003). Monitoring the uptake of protein-derived peptides by Porphyromonas gingivalis with fluorophore-labeled substrates. Curr Microbiol, 47(1): 1–4
|
/
〈 | 〉 |